Chabiotech Co.,Ltd.

Total Valuation

Chabiotech Co.,Ltd. carries a market capitalization of 789.87B, placing it among publicly traded companies globally. Its enterprise value stands at 2.23T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

The price-to-sales ratio is 0.94, and the price-to-book ratio stands at 5.49.

Enterprise Valuation

On an enterprise value basis, Chabiotech Co.,Ltd. trades at an EV/EBITDA multiple of 9.43 and an EV/FCF ratio of 15.82. The EV/Sales ratio of 1.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.43 provides insight into valuation relative to core operating earnings.

Financial Position

Chabiotech Co.,Ltd. maintains a current ratio of 0.88, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 93.60, indicating elevated leverage, while an interest coverage ratio of -1.21 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Chabiotech Co.,Ltd. has paid 3.13B in income taxes, reflecting an effective tax rate of 3,125.88.

Stock Price Statistics

Chabiotech Co.,Ltd.'s stock has declined approximately -8.39161% over the past 52 weeks. The 50-day moving average sits at 13,715.00, while the 200-day moving average is 15,235.80.

Income Statement

Over the trailing twelve months, Chabiotech Co.,Ltd. generated 1.29T in revenue and converted that into -73.45B in net income, yielding earnings per share of -1,511.81. EBITDA reached -66.42B, while operating income came in at -66.42B.

Balance Sheet

Chabiotech Co.,Ltd. holds 435.81B in cash and equivalents against 952.32B in total debt, resulting in a net debt position of 516.19B. Total book value stands at 220.84B, with working capital of -140.75B providing operational flexibility.

Cash Flow

Chabiotech Co.,Ltd. produced -103.34B in operating cash flow over the past twelve months. After subtracting -188.04B in capital expenditures, free cash flow totaled -291.38B - equivalent to -4,168.02 per share.

Margins

Chabiotech Co.,Ltd. operates with a gross margin of 28.39, reflecting its pricing power and cost economics. The operating margin of -5.13 and net profit margin of -5.68 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Chabiotech Co.,Ltd.'s most recent stock split took place on June 2, 2014 with a 5000:3631 split ratio.

Scores

Chabiotech Co.,Ltd. posts an Altman Z-Score of 0.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.